e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Asthma: mechanisms and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alveolar-capillary membrane dysfunction in heart failure: histopathological changes
F. M. Zampieri, M. Canzian, E. R. Parra, R. A. Kairalla, V. L. Capelozzi (São Paulo, Brazil)
Source:
Annual Congress 2008 - Asthma: mechanisms and treatment
Session:
Asthma: mechanisms and treatment
Session type:
Thematic Poster Session
Number:
3759
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. M. Zampieri, M. Canzian, E. R. Parra, R. A. Kairalla, V. L. Capelozzi (São Paulo, Brazil). Alveolar-capillary membrane dysfunction in heart failure: histopathological changes. Eur Respir J 2008; 32: Suppl. 52, 3759
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Diaphragm dysfunction in isoproterenol-induced heart failure
Source: Virtual Congress 2020 – From respiratory physiology to clinical practice: exercise and respiratory muscles
Year: 2020
Characterization of IH-induced cardiac remodeling and contractile dysfunction in a rat model of post-ischemic heart failure
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017
Role of mitochondria in the cardiac muscle from heart failure patients
Source: Annual Congress 2008 - Mitochondria in muscle-related respiratory disorders
Year: 2008
Nonrespiratory determinants of respiratory impairment in elderlypatients: heart failure and diabetes
Source: Eur Respir Mon; 2009: 43: 217–239
Year: 2009
Does heart failure make a difference in pulmonary function testing?
Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases
Year: 2020
Differences of functional capacity between patients with left heart failure and rightheart failure associated with chronic pulmonary diseases
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020
Impaired lung function and physical performance in chronic heart failure
Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease
Year: 2005
Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure
Source: Eur Respir J 2015; 46: 1430-1439
Year: 2015
Lung fibrosis - a disease of mitochondrial dysfunction
Source: International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease
Year: 2018
Peak exercise lung function in chronic heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 175s
Year: 2006
Mitochondrial dysfunction in chronic lung disease
Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease
Year: 2016
Lung function abnormalities in patients with heart failure and preserved ejection fraction
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012
Lung function evaluation in heart failure: possible pitfalls
Source: Breathe, 16 (1) 190316; 10.1183/20734735.0316-2019
Year: 2020
Cardiac remodelling and hemodynamic changes in pulmonary hypertension after double lung transplantation
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017
Association between right heart failure and endothelial dysfunction in COPD patients
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
The role of inflammation in chronic heart failure
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Pulmonary diffusion capacity in chronic heart failure is correlated with ventilation inhomogeneity rather than to direct haemodinamic impairment
Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases
Year: 2009
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 359-367
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept